Related Experiment Video
Updated: May 26, 2026
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Has nanotechnology led to improved therapeutic outcomes?
Stephanie Bosselmann1, Robert O Williams
1Division of Pharmaceutics, The University of Texas at Austin, Austin, TX 78712, USA. sbosselmann@utexas.edu
Drug Development and Industrial Pharmacy
|December 24, 2011
Summary
Nanoparticulate drug delivery systems offer significant advantages over conventional methods. Clinical trials show these advanced nanoparticle formulations improve therapeutic outcomes and enhance patient quality of life.
Area of Science:
- Drug delivery systems
- Nanotechnology
- Pharmaceutical sciences
Background:
- Conventional drug delivery systems face challenges with problematic drugs and diseases.
- Nanoparticulate systems present novel solutions for these challenges.
- Significant expectations exist for nanoparticles in advanced drug delivery.
Purpose of the Study:
- To review the benefits of nanoparticulate drug delivery systems.
- To compare nanoparticles with conventional delivery methods.
- To highlight marketed and developing nanoparticulate systems.
Main Methods:
- Literature review of nanoparticulate drug delivery systems.
- Analysis of clinical trial data comparing nanoparticle formulations with standard ones.
- Overview of current market and developmental status of these systems.
Main Results:
- Nanoparticulate formulations demonstrate superior therapeutic outcomes in clinical trials.
- These systems offer enhanced effectiveness compared to standard formulations.
- Several nanoparticulate drug delivery systems are currently marketed or in development.
Conclusions:
- Nanotechnology in drug delivery is a significant advancement.
- Nanoparticulate systems hold substantial potential for improving therapeutic effectiveness.
- These systems can lead to an increased quality of life for patients.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.